Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

209 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Tekturna (aliskiren)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9486-07 D-338-2014
Class II · Moderate risk

Tekturna (aliskiren)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9485-07 D-337-2014
Class II · Moderate risk

Stalevo (carbidopa, levodopa, and entacapone)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9407-01 D-336-2014
Class II · Moderate risk

Lescol XL (fluvastatin sodium)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9354-07 D-335-2014
Class II · Moderate risk

Exforge (amlodipine and valsartan, Tablets)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9491-07 D-334-2014
Class II · Moderate risk

Exforge (amlodipine and valsartan Tablets)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9489-07 D-333-2014
Class II · Moderate risk

Exforge HCT

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9560-89 D-332-2014
Class II · Moderate risk

Exforge HCT

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9559-89 D-331-2014
Class II · Moderate risk

Exforge HCT

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9563-89 D-330-2014
Class II · Moderate risk

Exforge (amlodipine and valsartan Tablets)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9490-07 D-329-2014
Class II · Moderate risk

Exforge (amlodipine and valsartan Tablets)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9488-07 D-328-2014
Class II · Moderate risk

Diovan (valsartan)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9360-07 D-327-2014
Class II · Moderate risk

Diovan (valsartan)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Terminated Chemical / undeclared Novartis Pharmaceuticals Corp. NDC 0078-9359-07 D-326-2014
Class II · Moderate risk

Lactated Ringer's Injection USP

Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).

Terminated Chemical / undeclared Baxter Healthcare Corp. NDC 0338-6307-02 D-1690-2012

Recalls by year